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In the mammalian circadian clockwork, CRY1 and
CRY2 repressor proteins are regulated by posttrans-
lational modifications for temporally coordinated
transcription of clock genes. Previous studies re-
vealed that FBXL3, an F-box-type E3 ligase, ubiquiti-
nates CRYs and mediates their degradation. Here,
we found that FBXL21 also ubiquitinates CRYs but
counteracts FBXL3. Fbxl21/mice exhibited normal
periodicity of wheel-running rhythms with compro-
mised organization of daily activities, while an
extremely long-period phenotype of Fbxl3/ mice
was attenuated in Fbxl3/Fbxl21 double-knockout
mice. The double knockout destabilized the behav-
ioral rhythms progressively and sometimes elicited
arrhythmicity. Surprisingly, FBXL21 stabilized CRYs
and antagonized the destabilizing action by FBXL3.
Predominantly cytosolic distribution of FBXL21
contrasts with nuclear localization of FBXL3. These
results emphasize the physiological importance of
antagonizing actions between FBXL21 and FBXL3
on CRYs, and their combined actions at different
subcellular locations stabilize oscillation of the circa-
dian clock.INTRODUCTION
Circadian rhythms with a period of approximately 24 hr are
generated by an internal timekeeping mechanism referred to
as the circadian clock (Takahashi, 1995, Dunlap, 1999). In
mammals, the central circadian pacemaker in the hypothalamic
suprachiasmatic nucleus (SCN) governs behavioral rhythms and
coordinates peripheral clocks located in a variety of tissues
(Schibler and Sassone-Corsi, 2002; Hastings et al., 2003). The1106 Cell 152, 1106–1118, February 28, 2013 ª2013 Elsevier Inc.mammalian circadian clocks are driven by a transcription-trans-
lation-based negative feedback loop. In the clockwork, CLOCK-
BMAL1 heterodimers activate transcription of PERIODs
(PER1-3) and CRYPTOCHROMEs (CRY1 and CRY2) through
binding to E-box enhancer-elements (Gekakis et al., 1998;
Bunger et al., 2000). Translated PER andCRY proteins associate
with each other, translocate into the nucleus, and repress their
own transcription through interaction with CLOCK-BMAL1
(Kume et al., 1999; Shearman et al., 2000). Among the clock
proteins, CRY1 and CRY2 act as key players in the mammalian
clockwork through their strong repressive activities on CLOCK-
BMAL1-dependent transcription (Kume et al., 1999; van der
Horst et al., 1999).
In addition to the transcriptional regulation, posttranslational
modifications of clock proteins have critical roles for the circa-
dian oscillation of the molecular clock (Toh et al., 2001; Gallego
and Virshup, 2007; Nolan and Parsons, 2009; Reischl and
Kramer, 2011).We previously reported a posttranslational mech-
anism regulating the stability of CRY2 protein. CRY2 is phos-
phorylated at Ser557 in a circadian manner in the mouse SCN
and liver (Harada et al., 2005; Kurabayashi et al., 2006). The
priming phosphorylation of CRY2 at Ser557 by DYRK1A allows
subsequent phosphorylation at Ser553 by GSK-3b, and the
two-step phosphorylation at the two neighboring Ser residues
of CRY2 leads to its proteasomal degradation (Kurabayashi
et al., 2010). On the other hand, CRY1 and CRY2 are ubiquiti-
nated by the Skp1-Cul1-FBXL3 (SCFFBXL3) ubiquitin ligase
complex (Busino et al., 2007), and the interaction of CRYs with
FBXL3, an F-box protein, is promoted by AMP-activated protein
kinase (AMPK)-mediated phosphorylation of CRYs (Lamia et al.,
2009). FBXL3-mediated ubiquitination of CRYs leads to their
proteasomal degradation, and two point mutations in mouse
Fbxl3, i.e., After-hour (Afh) and Overtime (Ovtm), each cause
remarkable lengthening of the free-running period of the mouse
behavioral rhythms (Siepka et al., 2007; Godinho et al., 2007).
However, CRY2-FBXL3 interaction and FBXL3-mediated CRY2
degradation do not require Ser557/Ser553 phosphorylation of
CRY2 (Kurabayashi et al., 2010). Thus, CRY proteins are subject
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Figure 1. Generation of Fbxl3 and Fbxl21
Knockout Mice
(A) Targeting vectors for generation of Fbxl3
knockout mice (Fbxl3/) and Fbxl21 knockout
mice (Fbxl21/).
(B) Southern blotting analysis of genomic DNA
from tails of mice with the indicated genotypes for
Fbxl3 (left) or Fbxl21 (right). The DNA was digested
with BglII and EcoRV for Fbxl3 or with EcoRI for
Fbxl21 genotyping. Hybridized probes are indi-
cated in (A).
(C) Fbxl3 (left) or Fbxl21 (right) mRNA levels in the
mouse liver quantified by real-time PCR. Data are
means + SEM (n = 3) for wild-type and Fbxl21/
mice and means + SD (n = 2) for Fbxl3/ mice.to degradation through at least two distinct pathways, postu-
lating the involvement of another E3 ligase in the phosphoryla-
tion-dependent degradation of CRY2. Hence, we focused our
attention on FBXL21, which is most similar in sequence to
FBXL3 (84% amino acid sequence identity) among the F-box-
type E3 ubiquitin ligase family (Jin et al., 2004; Dardente et al.,
2008). Despite the similarity between these FBXL proteins, the
physiological role of FBXL21 in the circadian clockwork remains
to be elucidated (Dardente et al., 2008).
In this study, we show that FBXL21 ubiquitinates CRYs and
that, surprisingly, FBXL21 stabilizes CRYs. FBXL21 localizes
predominantly in the cytosol, whereas FBXL3 is present in the
nucleus. Hence, the function and cellular distribution of FBXL21
form a sharp contrast with those of FBXL3 responsible for CRY
protein degradation. The double knockout of Fbxl3 and Fbxl21
alleviated the circadian period-lengthening phenotype of Fbxl3
knockout mice, further supporting their antagonizing actions on
CRYs. Importantly, the double knockout destabilized the central
clock in the SCN and progressively perturbed rhythmicity of the
circadian behaviors in constant darkness. The antagonizing
actions of Fbxl3 and Fbxl21 on CRY proteins have a critical role
for robust oscillation of the mammalian circadian clock.
RESULTS
Generation of Fbxl3 and Fbxl21 Knockout Mice
Afh andOvtm are two point-mutant alleles of Fbxl3 (Siepka et al.,
2007; Godinho et al., 2007). To evaluate the in vivo roles of Fbxl3Cell 152, 1106–1118, Fand its closely related paralog, Fbxl21, we
generated knockout mice lacking Fbxl3
and/or Fbxl21. We created targeting
vectors, in which IRES-lacZ and neo
cassettes were introduced into the
coding region of Fbxl3 or Fbxl21 gene
(Figure 1A). Germline transmission of the
mutant allele was confirmed by Southern
blot analysis (Figure 1B). Heterozygous
offspring crossed with C57BL/6 mice for
at least seven generations were inter-
crossed to produce Fbxl3 or Fbxl21
knockout mice. In both cases, the geno-
typic distribution of the offspring followedMendelian inheritance, and all the knockout mice used in the
present study were normal in appearance. The messenger
RNA (mRNA) levels of Fbxl3 and Fbxl21 in the liver of wild-
type, Fbxl3/, and Fbxl21/ mice were analyzed by real-time
PCR. Fbxl3 or Fbxl21 deficiency had no significant effect on
the expression levels of Fbxl21 or Fbxl3, respectively, when
compared to their mRNA levels in the wild-type liver (Figure 1C).
Fbxl3 and Fbxl21 Are Essential for Normal Behavioral
Rhythms
We examined the effects of deficiencies of Fbxl3 and/or Fbxl21
on the behavioral rhythms of mice by monitoring their wheel-
running activities (Figures 2A–2D). Fbxl3 null mice apparently en-
trained to the 12L:12D (LD) cycle, although the onset of active
phase was abnormally delayed from the light-to-dark transition
(Figure 2E; Table S1 available online). In constant darkness
(DD), Fbxl3-deficient mice showed rhythmic activities with
a free-running period (tDD) of 27.74 ± 0.20 hr (Figure 1F and Table
S1), which was significantly longer than that of their wild-type
littermates (tDD: 23.77 ± 0.06 hr). Such an extremely long period
in Fbxl3-deficient mice probably caused the delay of activity
onset in LD. When transferred from DD to LD, 5 out of 14 Fbxl3
knockout mice failed to entrain to the 24 hr cycle (Table S1)
and apparently free ran as they did in DD (Figure 2C), a pheno-
type also observed in Afh mutant mice (Godinho et al., 2007).
The circadian phenotype of Fbxl3-deficient mice (tDD: 27.74 ±
0.20 hr) was more severe than those of Fbxl3Afh/Afh (tDD:
26.5 hr, Godinho et al., 2007) and Fbxl3Ovtm/Ovtm (tDD: 26.21 hr,ebruary 28, 2013 ª2013 Elsevier Inc. 1107
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Figure 2. Wheel-Running Activity of Fbxl3 and Fbxl21 Knockout Mice
(A–D) Representative actograms of the wheel-running activities of wild-type (A), Fbxl3/ Fbxl21+/+ (B), Fbxl3+/+ Fbxl21/ (C), and Fbxl3/ Fbxl21/ (D). Mice
were entrained to LD cycle for at least 5 weeks, transferred to DD, and then transferred to LD again.
(legend continued on next page)
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Siepka et al., 2007). Thus, Fbxl3 plays an important role in the
regulation of the oscillation speed of the circadian clock in mice.
On the other hand, Fbxl21-deficient mice exhibited no signifi-
cant difference from their wild-type littermates in both the free-
running period in DD (Figure 2F) and activity onset in LD
(Figure 2E). However, an alteration in the daily activities was
obviously observed in Fbxl21 null mice: During the active period,
wild-type mice showed two peaks of activity bouts at early and
late night, the latter of which was eliminated in Fbxl21-deficient
mice (Figure 2G). This observation implies an involvement of
Fbxl21 in the SCN clock regulating temporal organization of
the daily activities.
The strong phenotype of Fbxl3 null mice in behavioral rhythm
(tDD: 27.74 ± 0.20 hr) was significantly attenuated in Fbxl3/
Fbxl21 double-knockout mice (Figures 2D and 2F; tDD: 25.59 ±
0.15 hr). The abnormal delay of the activity onset observed in
Fbxl3 knockout mice in LD was also alleviated in the double-
knockout mice (Figure 2E). However, we found that the
double-knockout mice exhibited unstable behavioral rhythms in
DD, although all of Fbxl3 single-knockout mice showed rhythmic
behaviors in DD: three out of ten Fbxl3/Fbxl21 knockout mice
were initially rhythmic but became arrhythmic within a fewweeks
after they were transferred to DD (Figure 2D, right panel; Table
S1). We estimated the robustness of the behavioral rhythms for
all the mice by the chi square periodogram procedure, where
robustness is expressedas theQpstatistic reflecting the strength
or regularity of a rhythm (Sokolove and Bushell, 1978). The
double-knockout mice showed a progressive decline in Qp
statistic during days 9–28 in DD (Figure 2H). This vulnerability
was not observed in Fbxl3 and Fbxl21 single-knockout mice (Fig-
ure 2H; Table S1). It is therefore evident that Fbxl3/Fbxl21 double
deficiency destabilized the circadian oscillator in the SCNwith no
significant effect on the daily levels of wheel-running activity (Fig-
ure 2I). We conclude that the combined actions of Fbxl21 and
Fbxl3 play a key role in the maintenance of both the speed and
the robustness of the circadian clock oscillation.
Fbxl21 Regulates the Oscillation Speed of Cellular
Clocks
A role of Fbxl21 in the cellular clock was investigated in NIH 3T3
cells. To monitor the cellular rhythms, we introduced a luciferase
reporter under the regulation ofBmal1 promoter into the cultured(E) Activity onset in LD cycle. The time of activity onset during the 5 days in LD just b
the onset times relative to the LD transition time were plotted. Error bars show S
(F) Circadian periods of free-running activities in DD determined by chi-square pe
the circadian periods. Error bars show SEM. *p < 0.05 by Tukey’s test.
(G) Activity profiles of Fbxl21/mice across the day. (Upper panel) Typical activit
hourly activities relative to the daily total activity in DD of everymouse for each gen
onset time was defined as circadian time 12.
(H) Temporal changes in periodogram amplitude (Qp) of the wheel-running activity
activity data during the four overlapping periods of 8 days in DD (DD1: days 9–
periodogram by using ClockLab software (Actimetrics). Error bars show SEM. *p
(I) The total numbers of the wheel revolutions per circadian cycle were counted d
significant (p > 0.05 by one-way ANOVA).
(J and K) Circadian periods of cellular rhythms in culture. NIH 3T3 cells were cotran
vectors targeting Fbxls (J, Fbxl21; K, Fbxl3 and/or Fbxl21). Forty-eight hours after
synchronize the cellular rhythms. The culture mediumwas then changed to the rec
calculated by using the data from the 2nd to the 4th peak. Error bars show SEMcells by transient transfection. Silencing of Fbxl21 was per-
formed by cotransfection of an expression plasmid of small
hairpin RNA (shRNA) sh21-1 or sh21-2 while Fbxl3 was
knocked down with sh3-1 or sh3-2 as described by Busino
et al. (2007). Among them, sh3-2 and sh21-2 abrogated the
expression of FBXL3 and FBXL21, respectively, and showed
no significant crossover effects with each other (Figure S1A).
We found that silencing of the Fbxl21 gene significantly short-
ened the period of the cellular rhythm (Figures 2J and S1B).
This period-shortening phenotype was not observed in the
behavioral rhythms of Fbxl21-deficient mice (Figure 2F). Gener-
ally, the behavioral rhythms are only marginally affected by
molecular defects in clock components due to the strong
coupling among the SCN neurons, whereas the phenotypes
often become manifest in the circadian rhythms of dispersed
cells in culture (Liu et al., 2007). It is likely that the effect of
Fbxl21 deficiency, i.e., speeding up of the molecular oscillation,
ismasked by the tight neuronal coupling in the SCN. On the other
hand, Fbxl3 knockdown remarkably lengthened the periods,
which were conversely shortened by additional knockdown of
Fbxl21 (Figures 2K and S1B). These results are consistent with
the behavioral phenotypes of the knockout mice.
Altered Molecular Rhythms in Fbxl21 Knockout Mice
To investigate how Fbxl21 deficiency affects the circadian clock-
work, we synchronized the cellular clocks in mouse embryonic
fibroblasts (MEFs) by a pulse treatment with dexamethasone
(Dex). We found that CRY1 and CRY2 protein levels in Fbxl21-
deficient MEFs were decreased and showed circadian oscilla-
tion with reduced amplitudes as compared with those in wild-
type MEFs (Figures 3A and 3B). On the other hand, the peak
mRNA levels of Cry1, Cry2, and Per1 were increased in Fbxl21
null MEFs (Figure 3C). These results suggest destabilization of
CRY proteins in Fbxl21-deficient MEFs. In contrast, the mRNA
levels of Dbp were decreased and Bmal1 mRNA levels were
elevated throughout the day (Figure 3C). Although Fbxl21-defi-
cient mice showed rhythmic behaviors with a period indistin-
guishable from that of wild-type mice (Figure 2C), transcriptional
control of the clock genes is remarkably perturbed in the
absence of Fbxl21. These molecular phenotypes can be at least
in part attributable to the dysregulation of CRY1 and CRY2 in
Fbxl21-deficient cells.efore the transition to DDwas determined by ClockLab software. Themeans of
EM. *p < 0.05 by Tukey’s test.
riodogram. Data from days 8 through 21 in DD were used for the calculation of
y profiles of wild-type and Fbxl21/mice in DD. (Lower panel) The ratios of the
otype were shownwith error bars of SEM. *p < 0.05 by Tukey’s test. The activity
rhythms of the knockout mice in DD. The Qp values were determined from the
16, DD2: days 13–20, DD3: days 17–24 and DD4: days 21–28) by chi-square
< 0.05 by one-way ANOVA.
uring 2 weeks (days 8–21) in DD. Error bars show SEM, and n.s. indicates not
sfected with a luciferase reporter (Bmal1us0.3-luc; Kon et al., 2008) and shRNA
the transfection, the cells were treated with 0.1 mM dexamethasone for 2 hr to
ording medium for recording bioluminescence signals. Circadian periods were
(n = 4, *p < 0.05 by Tukey’s test). See also Figure S1 and Table S1.
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Figure 3. Circadian Expression of CRY
Proteins and Clock Genes in Fbxl21
Knockout Mice
(A) Temporal changes in CRY1 and CRY2 protein
levels in Fbxl21/ MEFs. Cellular rhythms of
MEFs were synchronized by 2 hr pulse treatment
of 0.1 mM dexamethasone. The cells were har-
vested at 4 hr intervals followed by immunoblotting
with CRY1 or CRY2 antibody.
(B) The band densities of CRY1 or CRY2 in (A)
within a single blot were shown as values relative
to their average intensity in the blot, and the
highest value was set at 1.0. Data taken from three
independent experiments (i.e. three blots) were
averaged and shown with error bars of SEM (n = 3,
*p < 0.05 by Student’s t test).
(C) Temporal changes in mRNA levels of clock
genes in Fbxl21/ MEFs. Cellular rhythms of
MEFs were synchronized and total RNA was
prepared at 4 hr intervals. The mRNA levels of
Cry1, Cry2, Per1, Per2, Dbp, and Bmal1 were
quantified by real-time PCR, and the highest value
among the samples was set at 1.0. Data aremeans
with SEM (n = 3, *p < 0.05 by Student’s t test).FBXL21 Interacts with CRY Proteins
The abnormalities in temporal changes of CRY1 and CRY2
protein levels in Fbxl21-deficient MEFs suggest that FBXL21
shares with FBXL3 a regulatory mechanism determining CRY
protein levels. We first examined the interaction of FBXL21
with CRY1 and CRY2 in cultured cells. HEK293T17 cells were
transfected with expression constructs of myc-CRYs and Flag-
FBXLs. We found that, just like Flag-FBXL3, Flag-FBXL21 was
coimmunoprecipitated with myc-CRY1 and myc-CRY2 (Fig-1110 Cell 152, 1106–1118, February 28, 2013 ª2013 Elsevier Inc.ure 4A). The interaction between myc-
CRY1 and Flag-FBXL21 was verified by
coimmunoprecipitation of myc-CRY1
with Flag-FBXL21 (Figure 4B).
FBXL21 Forms an SCF Complex
Members of the F-box-type E3 ubiquitin
ligase family have a conserved F-box
domain and a substrate recognition
domain that is divergent among the
members. The F-box domain is important
for the formation of a Skp1-Cul1-F-box
protein (SCF) complex to exert E3 ligase
activity (Cardozo and Pagano, 2004). To
investigate E3 ligase activity of FBXL21,
we asked whether FBXL21 forms an
SCF complex. Recently, the authors
K.Y. and K.I.N. found that FBXL3
forms an SCF complex in a manner
dependent on CRY protein (unpublished
data). Based on this observation, we
coexpressed myc-CRY1 or myc-CRY2
with Flag-FBXL21 or Flag-FBXL3 in
HEK293T17 cells. Each myc-CRY facili-
tated the interaction of Skp1 and Cul1not only with Flag-FBXL3 but also with Flag-FBXL21 (Figure 4C).
It is most likely that FBXL3 and FBXL21 share the same domain
for CRY binding and that the E3 ligase activities of these F-box
proteins are regulated in a circadian manner through the
dynamic change in CRY protein levels. Here, we noticed that
Cul1 band in the precipitate with FBXLs was upshifted from
the Cul1 band in the input (Figure 4C). Because NEDD8 modifi-
cation of Cul1 is known to activate the SCF complex by recruiting
an E2 enzyme (Pan et al., 2004), the upshifted Cul1 band might
represent its neddylated state in the SCF complex containing
CRYs.
FBXL21 Ubiquitinates CRY Proteins
By using in vitro ubiquitination assay, we examined FBXL21-
catalyzed ubiquitination of CRY1 in the presence of 1 of 17 E2
enzymes. We found that UBE2A or UBE2D (D1-D3: UbcH5a-
5c) cooperated with not only FBXL3 but also FBXL21 in ubiquiti-
nating CRY1 (Figures 4D and S2A). We also found an in vivo
ubiquitination assay that cotransfection of Flag-FBXL3 or Flag-
FBXL21 enhanced myc-CRY1 ubiquitination in HEK293T17
cells (Figures 4E and S2B) and NIH 3T3 cells (Figure S2C).
Among various linkage types of ubiquitin chains, K48-linked
polyubiquitination is primarily known as the protein degradation
signal (Behrends and Harper, 2011). The linkage modes of
FBXL21- and FBXL3-mediated ubiquitination were examined
by using a mutant ubiquitin, HA-K48-Ub, in which all Lys resi-
dues except for K48 were mutated to Arg. Coexpression of
Flag-FBXL3 or Flag-FBXL21 with HA-wt-Ub promoted myc-
CRY1 ubiquitination to be nearly comparable to each other. On
the other hand, coexpression with HA-K48-Ub attenuated
myc-CRY1 ubiquitination catalyzed by FBXL21 when compared
to that achieved with FBXL3 (Figure 4F). These results suggest
that FBXL3 and FBXL21 elongate different types of ubiquitin
chains, at least in terms of their dependence on K48 linkage.
Further studies using a series of other mutant ubiquitins (such
as K11-Ub, K48R-Ub, and K63-Ub) would help to identify the
linkage mode of ubiquitin chains formed by FBXL21. We then
asked whether CRYs are endogenous substrates of FBXL21 in
NIH 3T3 cells by knockdown of Fbxl21. Silencing of Fbxl21 or
Fbxl3 reduced the ubiquitinated levels of myc-CRY1 in NIH
3T3 cells (Figures 4G and S2D). These results indicate that
CRY1 is an endogenous substrate for FBXL21- and FBXL3-cata-
lyzed ubiquitination.
FBXL21 Stabilizes CRY Proteins
Ubiquitination of proteins confers various regulations on modi-
fied proteins, such as protein stability, signal transduction,
enzymatic activity, and subcellular localization (Chen and Sun,
2009), whereas F-box protein-mediated ubiquitination predom-
inantly leads the substrates to proteasomal degradation (Car-
dozo and Pagano, 2004). We asked whether FBXL21 regulates
stabilities of CRYs by quantifying the steady-state protein levels
of Flag-His-myc-tagged CRY1 (FHM-CRY1) when FBXL21 and/
or FBXL3 are either overexpressed or knocked down. Overex-
pression of Flag-FBXL3 in HEK293T17 cells decreased FHM-
CRY1 protein levels, indicating that FBXL3 promotes CRY1
degradation (Figure 5A). In contrast, overexpression of Flag-
FBXL21 remarkably elevated FHM-CRY1 levels (Figure 5A).
Coexpression of Flag-FBXL3 and Flag-FBXL21 restored FHM-
CRY1 levels (Figure 5A), and the restoration was dose depen-
dent for Flag-FBXL21 (Figure 5B). Similar results were obtained
in experiments performed with FHM-CRY1 in NIH 3T3 cells (Fig-
ure S3A) or with FHM-CRY2 in NIH 3T3 cells (Figure S3B), sug-
gesting that FBXL3 and FBXL21 act on CRY proteins in a mutu-
ally antagonizing manner. Myc-PER2 also binds to Flag-FBXL3
and Flag-FBXL21, possibly via indirect interaction through
CRYs (Figure S3C), but myc-PER2 protein levels were mostlyunaffected by coexpression with Flag-FBXL21 and/or Flag-
FBXL3 (Figure S3D). An increase in Flag-FBXL21 levels had
no discernible effect on Flag-FBXL3 level (Figures 5A and 5B),
eliminating the possibility that the effect of overexpressed
Flag-FBXL21 on FHM-CRY1 was due to the change of FBXL3
levels. Meanwhile, knockdown of Fbxl21 by sh21-2 in NIH 3T3
cells resulted in a decrease in the steady-state levels of FHM-
CRY1, whereas knockdown of Fbxl3 increased FHM-CRY1
levels (Figure 5C). Collectively, these results indicate that
CRY1 levels are regulated by FBXL21 and FBXL3 antagonisti-
cally, where FBXL21 increases CRY1 levels probably through
its stabilization.
To confirm that the stability of CRY proteins is increased by
FBXL21, we investigated the degradation rate of myc-CRY1
protein in cultured cells. HEK293T17 cells expressing myc-
CRY1 and Flag-FBXLs were treated with cycloheximide (CHX)
for 3–6 hr. Expression of Flag-FBXL3 increased myc-CRY1
degradation rate, while Flag-FBXL21 expression significantly
suppressed the degradation (Figure 5D). Coexpression of Flag-
FBXL3 and FBXL21 attenuated FBXL3-dependent myc-CRY1
degradation. A similar set of experiments in NIH 3T3 cells
confirmed the stabilizing effect of Flag-FBXL21 on FHM-CRY1
(Figures S3E and S3F). The half-life of luciferase activity of
CRY1-LUC fusion protein was markedly increased (two-fold)
by Flag-FBXL21 expression (Figure 5E), whereas the lifetime of
LUC itself was unaffected by Flag-FBXL3 or Flag-FBXL21 (Fig-
ure S3G). In Fbxl21 knockout MEFs, by contrast, the decay of
CRY2 was significantly faster than that in wild-type MEFs (Fig-
ure 5F). These results demonstrate an important role of
FBXL21 in CRY protein stabilization, which antagonizes the de-
stabilizing action by FBXL3.
Ubiquitination Sites in CRY1 and CRY2
We investigated ubiquitination sites in CRY proteins by shotgun
proteomic analysis of FHM-tagged CRY1 or CRY2, each of
which was immunopurified from the lysates of NIH 3T3 cells
(Table 1). We found a series of ubiquitinated residues in FHM-
CRYs: K159, K329, and K485 in FHM-CRY1 and K125, K241,
K347, K474, and K503 in FHM-CRY2 (Figure 6A, K is labeled
with an asterisk). In addition, we found ubiquitinated residues
in ubiquitin copurifed with FHM-CRYs: K11, K48, and K63 (Table
1). A recent study of human ubiquitin-modified proteome identi-
fied ubiquitinated residues K329 and K442 in CRY1 and K241
and K474 in CRY2 (Kim et al., 2011). The present analysis
covered three out of the four ubiquitinated sites reported for
human CRYs and revealed two and three additional sites in
mouse CRY1 and CRY2, respectively. CRY proteins are multiply
ubiquitinated in vivo, suggesting the possibility that FBXL21 and
FBXL3 each catalyzes ubiquitination at a distinct subset of Lys
residues in CRYs. To examine whether ubiquitination of these
sites is essential for FBXL21-mediated stabilization of CRY1,
we generated four mutants of myc-CRY1 (mut1–4) by intro-
ducing a K-to-R mutation, respectively, at K107, K329, K456,
and K485, Lys residues which are ubiquitinated in CRY1 and/
or CRY2 and are conserved between CRY1 and CRY2 (Fig-
ure 6A). Among these mutants, mut1-CRY1 (K107R) protein
levels were sensitive to FBXL3-dependent degradation and, by
contrast, they were unaffected by coexpression of FBXL21 inCell 152, 1106–1118, February 28, 2013 ª2013 Elsevier Inc. 1111
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Figure 4. Interaction of FBXL21 with CRY1 and CRY2
(A) Interaction of FBXL21 with CRY1 and CRY2 in HEK293T17 cells. Cells were transfected with myc-CRYs and Flag-FBXL3 or Flag-FBXL21 expression vectors.
Forty-eight hours after the transfection, the cells were harvested and lysed in IP buffer, followed by immunoprecipitation with anti-myc antibody. Immunopre-
cipitated product was analyzed with anti-Flag antibody.
(B) Myc-CRY1 and Flag-FBXL3 or FBXL21 were expressed in HEK293T17 cells and Flag-FBXLs were immunoprecipitated with anti-Flag antibody. Interaction of
FBXL3 or FBXL21 with myc-CRY1 was detected with anti-myc antibody.
(C) FBXL21 forms SCF complex with CRY proteins. Flag-FBXLs and myc-CRY1 expression constructs were transfected into HEK293T17 cells. Interaction of
FBXL21 with endogenous Cul1 and Skp1 were detected with anti-Cul1 and anti-Skp1 antibody.
(legend continued on next page)
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HEK293T17 cells (Figures 6B and 6C). The other three mutant
proteins (mut2–4) were mostly sensitive to both FBXL3-depen-
dent degradation and FBXL21-dependent stabilization (Figures
6B and 6C). These observations suggest that FBXL21 stabilizes
CRY1 through ubiquitination of at least one unique Lys residue
K107, which is not involved in FBXL3-dependent degradation.
Subcellular Localization of FBXL21
Although the amino acid sequences of FBXL21 and FBXL3 are
highly conserved, their N-terminal regions are divergent from
each other. We found in this region a putative nuclear localization
signal (NLS) sequence KRPR only in FBXL3 (Figure 6D). Interest-
ingly, the NLS sequence at the corresponding position of
FBXL21 is disrupted by amino acid insertion (Figure 6D). To
reveal the spatial regulation of CRY ubiquitination, we examined
subcellular distribution of FBXL21, FBXL3, and NLS-mut-FBXL3
that have mutations KRPR-to-AAAA at positions 22–25. Flag-
FBXL3 was localized predominantly to the nucleus of
HEK293T17 cells as reported by Godinho et al. (2007), whereas
NLS-mutated Flag-FBXL3 was detected in the cytosol (Figures
6E and 6F), indicating that the NLS sequence is critical for
nuclear localization of FBXL3. In contrast, Flag-FBXL21 was
found in the cytosol with weak distribution in the nucleus (Figures
6E and 6F). Such a contrast in distribution suggests that CRY
stabilities are regulated by FBXL21 and FBXL3 predominantly
at different subcellular spaces. To reveal an impact of FBXL21
on nuclear and cytosolic CRYs, we investigated CRY levels in
these two fractions of the mouse brain lysate prepared at ZT18
from Fbxl3, Fbxl21, and Fbxl3/Fbxl21 knockout mice. As
compared to wild-type, Fbxl21-deficient mice showed reduced
levels of CRY1 and CRY2 in both the cytosol and the nucleus
(Figures 6G and 6H). In Fbxl3 null background, on the other
hand, Fbxl21 knockout decreased CRY levels only in the cytosol
(Figure 6H). These findings suggest that FBXL21 protects CRYs
from FBXL3-mediated degradation in the nucleus, where aminor
population of FBXL21 is located. The results also imply that at
least one additional CRY degradation system is operating in
the cytosol, where FBXL21 plays a major role for CRYs stabiliza-
tion. It is probable that the finely tuned accumulation of CRY
proteins in the cytosol mediated by FBXL21 in combination
with another degradation mechanism determines the proper
timing of their nuclear entry (Figure 6I).
DISCUSSION
In the present study, we provide evidence for the physiological
role of Fbxl21 in the regulation of the circadian clockwork.
FBXL3 and FBXL21 each bind with CRY1 and CRY2 (Figures
4A and 4B) and form an SCF complex (Figure 4C), which medi-(D) In vitro ubiquitination assay of CRY1. Recombinant ubiquitin, E1, E2 (UBE2D3)
30C. Ubiquitinated HA-CRY1 (Ub-HA-CRY1) was detected by immunoblotting w
(E) In vivo ubiquitination assay of CRY1. Flag-ubiquitin (Ub), myc-CRY1, and
transfection, the cells were treated with 10 mMMG132 for 6 hr. Ubiquitination of m
(F) In vivo ubiquitination assay of CRY1. HA-wt-Ub or HA-K48-Ub was coexpress
the transfection, the cells were treated with 10 mMMG132 for 6 hr. Ubiquitination o
The intensity of the smeared bands of polyubiquitinated CRY1 was quantified. D
(G) Fbxl21 knockdown reduced CRY1 ubiquitination. shRNA expression vectors t
10 mM MG132 for 6 hr before harvest. Ubiquitination of myc-CRY1 purified withates ubiquitination of CRY proteins (Figures 4D, 4E, and 4G).
Intriguingly, FBXL3 and FBXL21 regulate the stability of CRY
proteins in opposite directions despite the high degree of their
sequence identity (Figure 5). We found that the K-to-R mutation
in CRY1 at K107, one of the ubiquitination sites identified in the
present study (Table 1), attenuates FBXL21-dependent stabiliza-
tion and, by contrast, has no significant effect on FBXL3-depen-
dent degradation (Figures 6B and 6C). FBXL21 may exert its
stabilizing effect on CRYs through ubiquitination of K107 in
CRY1 and the corresponding residue K125 in CRY2. A CRY1
peptide, having ubiquitinated K107, was not detected in our
shotgun proteomic analysis, but we speculate that substantially
low ubiquitinated levels of CRY1 in NIH 3T3 cells could have
hampered its detection. The Lys residues at these positions
are conserved in CRY1 and CRY2 from a wide range of species,
including humans, chickens, zebrafish, Xenopus, and Anole
lizards (http://www.ensembl.org/), and CRY1 and CRY2 show
the high degree of amino acid identity at the surrounding
sequences, raising the possibility that K107 is a common site
for ubiquitination among vertebrate CRYs in vivo.
It is well established that F-box protein-mediated ubiquitina-
tion of proteins leads to their proteasome-dependent degrada-
tion (Pan et al., 2004; Frescas and Pagano, 2008). The only re-
ported exception to this paradigm is the stabilization of c-Myc
by b-TrCP-mediated polyubiquitination, which interferes with
FBXW7-mediated c-Myc ubiquitination that leads to its degrada-
tion (Popov et al., 2010). b-TrCP and FBXW7 competitively ubiq-
uitinate the same residue on c-Myc and conjugate different
linkage types of polyubiquitin chains. In this way, b-TrCP-medi-
ated polyubiquitination protects c-Myc against FBXW7-medi-
ated ubiquitination and degradation, and accordingly, b-TrCP
is effective only in the presence of FBXW7. In the case of CRY
proteins, it is likely that FBXL3 catalyzes elongation of K48-linked
polyubiquitin chain, whereas FBXL21 appears to elongate
a different type of ubiquitin chain (Figure 4F). In fact, we detected
K11- and K63-linked structures in ubiquitins copurified with CRY
proteins (Table 1). Our findings suggest FBXL21-mediated
formation of a polyubiquitin chain with a K11- or K63-linked
mode or a mode comprising a combination of K11, K63, or
K48 linkage. CRY proteins are probably stabilized by a mecha-
nism in which the ubiquitination of CRYs catalyzed by SCFFBXL21
could either compete with the formation of the K48-linked poly-
ubiquitin chain (the degradation signal) or interfere with the func-
tion of the degradation signal.
Here, we emphasize that the phenotypes of Fbxl21 ablation
are observed even in the absence of Fbxl3 at the behavioral level
(Figure 2F) and at the molecular level (Figures 5C and 6H). These
observations strongly suggest additional regulation of degrada-
tion-stabilization of CRYs operating in the cytosol, which is, Rbx1, Skp1-Cul1-FBXLs (SCFFBXLs), and HA-CRY1 were incubated for 2 hr at
ith anti-HA antibody.
Flag-FBXLs were expressed in HEK293T17 cells. Forty-two hours after the
yc-CRY1 purified with anti-myc antibody was detected by anti-Flag antibody.
ed with myc-CRY1 and Flag-FBXLs in HEK293T17 cells. Forty-two hours after
f myc-CRY1 purifiedwith anti-myc antibody was detected by anti-HA antibody.
ata are means + SEM (n = 3, *p < 0.05 by Student’s t test).
argeting Fbxls were transfected to NIH 3T3 cells and the cells were treated with
anti-myc antibody was detected by anti-Flag antibody. See also Figure S2.
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Figure 5. Effect of FBXL21 on the Stability of CRY Proteins
(A) Effect of FBXL21 on the steady-state levels of CRY1 protein. Flag-His-myc-CRY1 (FHM-CRY) and Flag-FBXL expression vectors were cotransfected to
HEK293T17 cells. Forty-eight hours after the transfection, CRY1 expression levels were quantified by immunoblotting with CRY1 antibody. Data are means +
SEM (n = 3, *p < 0.05 by Tukey’s test).
(B) FBXL21 dose dependently restored CRY1 protein levels that were reduced by FBXL3. The amounts of the plasmid for Flag-FBXL21 expression were 0, 50,
100, and 200 ng. EGFP was used for a loading control.
(C) Effect of Fbxl21 knockdown on the steady-state levels of CRY1 protein. shRNA expression vectors (sh3-2 or sh21-2) were transfected to NIH 3T3 cells.
Seventy-two hours after the transfection, CRY1 levels were quantified by immunoblotting with CRY1 antibody. Data are means + SEM (n = 3, *p < 0.05 by Tukey’s
test or Dunnett’s test).
(D) Degradation assay of myc-CRY1. Flag-FBXLs and myc-CRY1 were expressed in HEK293T17 cells. Forty-eight hours after the transfection, the cells were
treated with 100 mg/ml CHX for 3 or 6 hr. Then, the cells were harvested, followed by immunoblotting with CRY1 antibody. CRY1 levels at time zero in each
condition were normalized to 1.0. Data are means + SEM (n = 3; *p < 0.05 by Tukey’s test between empty and FBXL21; #p < 0.05 by Tukey’s test between FBXL3
and FBXL3+FBXL21).
(E) Degradation assay of CRY1-LUC. CRY1-LUC and Flag-FBXLs were expressed in HEK293T17 cells. Forty-eight hours after the transfection, bioluminescence
levels were monitored in the recording medium containing CHX. Half-life of CRY1-LUC was calculated by fitting the data with an exponential function and shown
with error bars of SEM (n = 4, *p < 0.05 by Tukey’s test).
(F) Degradation assay of endogenous CRY2 in Fbxl21/MEFs. MEFs were treated with CHX for 3 or 6 hr and then harvested, followed by immunoblotting with
CRY2 antibody. The protein levels at time zero in each genotype were normalized to 1.0. Data are means + SEM (n = 3, *p < 0.05 by Student’s t test). See also
Figure S3.
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Table 1. Ubiquitination Sites Identified by Shotgun Proteomic
Analysis
Proteina Position Ubiquitinated Peptideb
CRY1
153–177 FQTLVSK159MEPLEMPADTITSDVIGK
323–334 NPEALAK329WAEGR
484–493 MK485QIYQQLSR
CRY2
114–127 LTFEYDSEPFGK125ER
239–245 LDK241HLER
341–352 NPEALAK347WAEGK
461–477 YIYEPWNAPESVQK474AAK
502–511 MK503QIYQQLSR
Ubiquitin
7–27c TLTGK11TITLEVEPSDTIENVK
43–54d LIFAGK48QLEDGR
55–72d TLSDYNIQK63ESTLHLVLR
aFHM-CRY1, FHM-CRY2 or FH-LacZ purified from NIH 3T3 lysate was
subjected to shotgun proteomic analysis (see Extended Experimental
Procedures for details).
bGlycylglycine was found to be linked via an amide bond to the epsilon
amino group of the lysine residue (K) underlined. These residues were as-
signed as the attachment sites of ubiquitin because glycylglycine is
derived from its C-terminal sequence RGG after proteolysis with trypsin.
cA peptide detected from the analysis of CRY2.
dPeptides detected from the analyses of both CRY1 and CRY2.obviously different from the dual regulation by FBXL21 and
FBXL3 in the nucleus. FBXL21-mediated stabilization and the
counterbalancing degradation of CRYs in the cytosol are critical
for determining the accumulation rate of CRY proteins.We previ-
ously reported a CRY2 degradation mechanism dependent on
Ser557/Ser553 phosphorylation in the cytosol (Kurabayashi
et al., 2010). However, the binding affinity of CRY2 to FBXL21
was unaffected by S557A mutation, and S557A-CRY2 protein
levels were increased by coexpression of FBXL21 (data not
shown). Thus, FBXL21 is less likely to be involved directly in
Ser557/Ser553 phosphorylation-dependent degradation of
CRY2. Multiple ubiquitination sites in CRY1 and CRY2 (Table 1)
are indicative of a complex network of CRY ubiquitination that
is important for the circadian clockwork.
Fbxl21 knockout mice showed wheel-running rhythms in DD
with a period indistinguishable from that of their wild-type litter-
mates (Figure 2F). On the other hand, the Takahashi laboratory
(UT Southwestern, USA) found a point mutation in FBXL21 that
causes a shortened period of behavioral rhythms (Yoo et al.,
2013, this issue of Cell). This short-period phenotype is consis-
tent with our observation on the cellular clock, in which silencing
of Fbxl21 in NIH 3T3 cells significantly shortened the period (Fig-
ure 2J). We speculate that Fbxl21 slows down the oscillation
speed and that the difference in phenotypes of Fbxl21 ablation
between behavioral and cellular rhythms (Figures 2F and 2J)
may be explained by consolidation of the circadian oscillation
in the SCN (Liu et al., 2007). It is noteworthy that Fbxl21 null
mice showed a decrease in wheel-running activities near the
subjective dawn (Figure 2G). Thus, Fbxl21 deficiency appearsto also affect the SCN clock function regulating the temporal
organization of the behaviors. The profound and complex pertur-
bations in the circadian expression profiles of the clock genes
(Figure 3C) might be responsible for this abnormality, though
the underlying mechanism has yet to be elucidated.
Fbxl21 knockout in Fbxl3 null background significantly short-
ened the long circadian period of the behavioral rhythm of
Fbxl3 null mice (Figure 2). This result can be explained by the
antagonizing effects of FBXL21 and FBXL3 on CRY stabilities.
Importantly, despite the apparent alleviation of the abnormalities
of Fbxl3 knockout mice in terms of the circadian period and the
activity onsets, Fbxl3/Fbxl21 double-knockout mice exhibited
unstable circadian behaviors as revealed by the occurrence of
arrhythmicmice in DD (three out of tenmice; Figure 2D and Table
S1) and by the progressive decline in the periodogram amplitude
(Qp) during days 9–28 in DD (Figure 2H). Qp is a measure of
robustness of circadian rhythms (Sokolove and Bushell, 1978),
and the values were unaltered in Fbxl3 and Fbxl21 single-
knockout mice in DD (Figure 2H). We conclude that FBXL21
and FBXL3 cooperatively play an essential role for the mainte-
nance of the robust clock oscillation by providing a mechanism
counterbalancing CRY1 and CRY2 protein levels.
Here we propose a model in which CRY proteins are regulated
by FBXL21 and FBXL3 so as to maintain normal circadian oscil-
lation (Figure 6I). FBXL21-mediated ubiquitination of CRY1 and
CRY2 provides an 12 hr time window for accumulation of
CRY proteins in the cytosol when the E-box-dependent tran-
scription is kept active. This idea is supported by the subcellular
distribution of FBXL21 (Figure 6E) and by the marked reduction
of CRY levels in Fbxl21-deficient cells (Figures 3B and 6H).
Fbxl21 transcripts show marked circadian variations in the
mouse SCN (Dardente et al., 2008), and Fbxl21 mRNA levels
are high during the mid- to late-subjective day when Cry1 and
Cry2 mRNA levels increase. It is most likely that FBXL21 plays
an important role for temporally organizing the accumulation of
translated CRYs in the cytosol. On the other hand, FBXL3 ubiq-
uitinates CRYs predominantly in the nucleus to terminate
suppression of the E-box-dependent transcription (Godinho
et al., 2007). Collectively, a spatiotemporally fine-tuned balance
between stabilization and degradation mediated by FBXL21 and
FBXL3, respectively, is essential for coordinating the24 hr vari-
ation of protein abundance of CRY1 andCRY2, the key players in
the transcription-based autoregulatory feedback in the circadian
clock.
Ubiquitination-mediated degradation of clock proteins, espe-
cially that of the transcriptional repressors, has been highlighted
as a key regulatory process in the clockwork of many organisms
(Gallego and Virshup, 2007; Baker et al., 2012; Ito et al., 2012). In
the present study, we demonstrate that coordination of a desta-
bilizer, FBXL3, with a stabilizer, FBXL21, each acting antagonis-
tically on CRY repressors, is critical for generating the CRY
expression dynamics and behavior rhythms. CRY protein levels
are critical determinants of the timing of CLOCK-BMAL1-depen-
dent transcriptional activation. Thus, the balance between CRY
stabilization and degradation mediated by a combination of
FBXL21 and FBXL3 is essential to drive the 24 hr cycle of the
circadian clock. Our results underscore an emerging concept
that switching between protein degradation and stabilizationCell 152, 1106–1118, February 28, 2013 ª2013 Elsevier Inc. 1115
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directed by posttranslational modifications (Brooks and Gu,
2003; Perkins, 2006) underlies the regulatory processes of
many biological events.
EXPERIMENTAL PROCEDURES
Animals
All the mouse experiments were approved by the animal ethics committee of
The University of Tokyo and Kyushu University. Mice were housed in cages
with free access to commercial chow (CLEA Japan) and tap water. See
Extended Experimental Procedures for details on the generation of Fbxl3/
and Fbxl21/ mice.
Wheel-Running Activity
Five- to ten-week-old mice were housed individually in cages equipped with
running wheels. The animals were maintained in a light-tight chamber at
a constant temperature (23C ± 1C) and humidity (65% ± 10%). Mice were
entrained to the LD cycle for at least 5 weeks and released into DD for
21 days or longer. Wheel revolutions were recorded in 5min bins and analyzed
with ClockLab analysis software (Actimetrics). The circadian period and perio-
dogram amplitude of the activity rhythms in DD were determined using chi-
square periodogram procedure with ClockLab.
Cell Culture and Plasmids for Transfection
MEFs were prepared from E12.5 embryos. After the head, paws, and internal
organswere removed, embryoswere chopped and incubated in 0.25% trypsin
in PBS for 24 hr at 4C. After incubation for 30 min at 37C in 0.25% trypsin in
PBS, cells were dissociated by pipetting. MEFs, NIH 3T3 (Riken Cell Bank),
and HEK293T17 cells were cultured and passaged under 5% CO2 in DMEM
(Nissui) containing 1.8 mg/ml NaHCO3, 4.5 mg/ml glucose, 100 U/ml penicillin,
100 mg/ml streptomycin, and 10% fetal bovine serum (Equitech Bio). NIH 3T3
and HEK293T17 cells were transiently transfected using Lipofectamine Plus
reagent (Invitrogen) and Lipofectamine 2000 reagent (Invitrogen), respectively,
according to the manufacturer’s protocols. Plasmids used for transfection are
described in the Extended Experimental Procedures.
Immunoblotting
Proteins separated by SDS-PAGEwere transferred to polyvinylidene difluoride
membrane (Millipore). The blots were blocked in a blocking solution (1% [w/v]
skimmilk in TBS [50mM Tris-HCl, 140mMNaCl, 1mMMgCl2 (pH 7.4)]) for 1 hr
at 37C and then incubated overnight at 4C with a primary antibody in the
blocking solution. The signals were visualized by an enhanced chemilumines-
cence detection system (PerkinElmer Life Science). The blot membrane was
subjected to densitometric scanning and the band intensities were quantifiedFigure 6. Identification of Ubiquitination Sites by Mass Spectrometry A
(A) Ubiquitination sites in CRY1 and CRY2 identified by mass spectrometry analy
Flag antibody and subjected to mass spectrometry analysis. Ubiquitinated Lys re
The gray horizontal bar indicates a region highly conserved between mouse CRY
(B) Effect of coexpression of FBXL3 or FBXL21 onmutant CRY1 protein levels. Mu
levels of CRY1 protein were determined by immunoblotting analysis with CRY1 an
respectively.
(C) Each mut-CRY1 protein levels were quantified and shown with error bars of
(D) Mouse FBXL3 has an NLS sequence, which is not conserved in FBXL21.
(E) Intracellular distribution of FBXL3, NLS-mut-FBXL3, and FBXL21. Flag-FBXL3,
immunostained with anti-Flag antibody. Cell nuclei were stained with DAPI.
(F) Quantitative analysis of the subcellular distribution of FBXL3, NLS-mut-FBXL3,
(E), and in each experiment at least 100 cells were visually examined and counte
(G) CRY1 and CRY2 protein levels in themouse cerebrum. Themouse cerebrum ly
The same amounts of proteins (50 mg cytosolic proteins or 20 mg nuclear protein
(H) The band intensities of CRY1 and CRY2 in (G) were quantified and the highest v
(I) In the cytosol, FBXL21 stabilizes CRY proteins, probably by counterbalancin
mulation of translated CRYs in their increasing phase during the daytime. In the nu
by FBXL21-mediated stabilization, in the declining phase of CRYs during the night
FBXL3 plays a critical role for robust oscillation of the circadian clock.using Image Gauge Ver.4.0 software (Fujifilm Science Lab). Antibodies were
described in the Extended Experimental Procedures.
Degradation Assay
Cells were transfected with FHM- or myc-CRY1 and Flag-FBXLs expression
vectors and cultured for 48 hr. The transfected cells were then treated with
100 mg/ml cycloheximide (Nakalai tesque) for time periods specified in the
figures and harvested, followed by immunoblotting. Degradation assay in
cultured MEFs was performed in essentially the same way except that DNA
was not transfected.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, one table, and Extended
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.cell.2013.01.054.
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